Skip to main content
    E

    Elicio Therapeutics Inc. (ELTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.48
    -0.02 (-1.33%)

    Market Cap: $42.46M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Elicio Therapeutics Inc. (ELTX) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Elicio Therapeutics (ELTX) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Elicio Therapeutics reported EPS of -$0.30, above the -$0.42 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    35%(6/17)
    Avg Surprise
    -14.72%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.35
    Range-$0.41 - -$0.33
    6 analysts
    Revenue Consensus
    N/A
    RangeN/A
    6 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.37
    Range-$0.51 - -$0.29
    3 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.63+41.8%
    60d ago-$0.54+31.7%
    30d ago-$0.44+16.0%
    7d ago-$0.44+16.0%
    Current-$0.37
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    ELTX has an expected report date of Mar 10, 2027.

    Earnings History

    Of the 17 quarters below that had an estimate, ELTX beat 6, missed 10 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2023, when EPS landed 124.36% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.30-$0.42-$0.48 - -$0.40+28.57%BeatN/A40 up, 0 downNov 5, 2026N/A
    Jun 30, 2026-$0.43-$0.53-$0.60 - -$0.45+18.87%BeatN/A4N/AAug 13, 2026N/A
    Mar 31, 2026-$0.65-$0.46-$0.49 - -$0.44-41.30%MissN/A20 up, 1 downMay 11, 2026N/A
    Dec 31, 2025-$0.49-$0.45-$0.47 - -$0.42-10.11%MissN/A21 up, 0 downMar 12, 2026N/A
    Sep 30, 2025-$0.60-$0.48-$0.48 - -$0.48-25.00%MissN/A10 up, 1 downNov 13, 2025N/A
    Jun 30, 2025-$0.66-$0.69-$0.69 - -$0.68+4.35%BeatN/A20 up, 0 downAug 7, 2025N/A
    Mar 31, 2025-$0.87-$0.83-$1.15 - -$0.64-4.82%MissN/A30 up, 1 downMay 13, 2025N/A
    Dec 31, 2024-$1.02-$0.88-$0.99 - -$0.76-16.57%MissN/A2N/AMar 31, 2025$1.17M
    Sep 30, 2024-$1.39-$0.73-$0.95 - -$0.57-90.41%MissN/A31 up, 1 downNov 13, 2024N/A
    Jun 30, 2024-$0.64-$0.96-$1.04 - -$0.88+33.33%BeatN/A20 up, 0 downAug 13, 2024N/A
    Mar 31, 2024-$1.15-$1.09-$1.21 - -$0.97-5.50%MissN/A21 up, 0 downMay 15, 2024N/A
    Dec 31, 2023-$1.75-$0.78-$1.03 - -$0.54-124.36%MissN/A20 up, 0 downFeb 13, 2024N/A
    Sep 30, 2023-$1.27-$0.80N/A-58.75%MissN/AN/AN/ANov 9, 2023N/A
    Jun 30, 2023-$2.44N/AN/AN/AN/AN/AN/A0 up, 0 downAug 11, 2023N/A
    Mar 31, 2023-$1.51N/AN/AN/AN/AN/AN/A0 up, 0 downMay 10, 2023N/A
    Dec 31, 2022-$2.10-$2.10N/A0.00%In lineN/AN/AN/AMar 29, 2023N/A
    Sep 30, 2022-$3.00-$3.60N/A+16.67%BeatN/AN/AN/ANov 14, 2022N/A
    Jun 30, 2022-$3.00-$4.63N/A+35.21%BeatN/AN/AN/AAug 16, 2022N/A
    Mar 31, 2022-$4.80-$4.35N/A-10.34%MissN/AN/AN/AJun 29, 2022$1.65M
    Sep 30, 2021-$5.26N/AN/AN/AN/AN/AN/AN/ANov 12, 2021$1.46M
    Jun 30, 2021-$0.45N/AN/AN/AN/AN/AN/AN/ASep 28, 2021$540000
    Mar 31, 2021-$15.65N/AN/AN/AN/AN/AN/AN/AJun 29, 2021$371000
    Last 22 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$2.62, after -$4.20 the year before. It was -$34.26 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$2.62N/A
    Dec 31, 2024-$4.20N/A
    Dec 31, 2023-$6.96N/A
    Dec 31, 2022-$34.26N/A

    Frequently Asked Questions About ELTX

    When is Elicio Therapeutics's next earnings date?

    Elicio Therapeutics's next earnings report is expected for Mar 10, 2027.

    Did ELTX beat earnings estimates last quarter?

    Yes. Elicio Therapeutics reported EPS of -$0.30 for the quarter ended Sep 30, 2026, above the -$0.42 estimate, a 28.57% surprise.

    What EPS do analysts expect from ELTX next quarter?

    The consensus EPS estimate for Elicio Therapeutics for the quarter ending Dec 31, 2026 is -$0.35 from 6 analysts, with estimates from -$0.41 to -$0.33.

    How often does ELTX beat earnings estimates?

    Elicio Therapeutics beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -5.75%.